Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 2414

1.

Evaluation of Translife Care: An Intervention to Address Social Determinants of Engagement in HIV Care Among Transgender Women of Color.

Kuhns LM, Hotton AL, Perloff J, Paul J, Parker C, Muldoon AL, Johnson AK, Garofalo R.

AIDS Behav. 2019 Jun 5. doi: 10.1007/s10461-019-02548-y. [Epub ahead of print]

PMID:
31165937
2.

Addition of Docetaxel to First-line Long-term Hormone Therapy in Prostate Cancer (STAMPEDE): Modelling to Estimate Long-term Survival, Quality-adjusted Survival, and Cost-effectiveness.

Woods BS, Sideris E, Sydes MR, Gannon MR, Parmar MKB, Alzouebi M, Attard G, Birtle AJ, Brock S, Cathomas R, Chakraborti PR, Cook A, Cross WR, Dearnaley DP, Gale J, Gibbs S, Graham JD, Hughes R, Jones RJ, Laing R, Mason MD, Matheson D, McLaren DB, Millman R, O'Sullivan JM, Parikh O, Parker CC, Peedell C, Protheroe A, Ritchie AWS, Robinson A, Russell JM, Simms MS, Srihari NN, Srinivasan R, Staffurth JN, Sundar S, Thalmann GN, Tolan S, Tran ATH, Tsang D, Wagstaff J, James ND, Sculpher MJ.

Eur Urol Oncol. 2018 Dec;1(6):449-458. doi: 10.1016/j.euo.2018.06.004. Epub 2018 Sep 14.

PMID:
31158087
3.

This is a platform alteration: a trial management perspective on the operational aspects of adaptive and platform and umbrella protocols.

Schiavone F, Bathia R, Letchemanan K, Masters L, Amos C, Bara A, Brown L, Gilson C, Pugh C, Atako N, Hudson F, Parmar M, Langley R, Kaplan RS, Parker C, Attard G, Clarke NW, Gillessen S, James ND, Maughan T, Sydes MR; past and present members of the STAMPEDE and FOCUS4 Trial Management Group.

Trials. 2019 May 29;20(1):264. doi: 10.1186/s13063-019-3216-8.

4.

Adverse Events and Nocebo Effects in Inflammatory Bowel Disease: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.

Ma C, Panaccione NR, Nguyen TM, Guizzetti L, Parker CE, Hussein IM, Vande Casteele N, Khanna R, Dulai PS, Singh S, Feagan BG, Jairath V.

J Crohns Colitis. 2019 May 3. pii: jjz087. doi: 10.1093/ecco-jcc/jjz087. [Epub ahead of print]

PMID:
31111881
5.

A Four-Group Urine Risk Classifier for Predicting Outcome in Prostate Cancer Patients.

Connell SP, Hanna M, McCarthy F, Hurst R, Webb M, Curley H, Walker H, Mills R, Ball RY, Sanda MG, Pellegrini KL, Patil D, Perry AS, Schalken J, Pandha H, Whitaker H, Dennis N, Stuttle C, Mills IG, Guldvik I; Movember GAP1 Urine Biomarker Consortium, Parker C, Brewer DS, Cooper CS, Clark J.

BJU Int. 2019 May 20. doi: 10.1111/bju.14811. [Epub ahead of print]

PMID:
31106513
6.

Optimizing the Timing of Salvage Postprostatectomy Radiotherapy and the Use of Concurrent Hormonal Therapy for Prostate Cancer.

Kishan AU, Tendulkar RD, Tran PT, Parker CC, Nguyen PL, Stephenson AJ, Carrie C.

Eur Urol Oncol. 2018 May;1(1):3-18. doi: 10.1016/j.euo.2018.02.008. Epub 2018 May 15. Review.

PMID:
31100226
7.

Findings in Stillbirths Associated with Placental Disease.

Gibbins KJ, Pinar H, Reddy UM, Saade GR, Goldenberg RL, Dudley DJ, Drews-Botsch C, Freedman AA, Daniels LM, Parker CB, Thorsten V, Bukowski R, Silver RM.

Am J Perinatol. 2019 May 14. doi: 10.1055/s-0039-1688472. [Epub ahead of print]

PMID:
31087311
8.

The Campylobacter jejuni helical to coccoid transition involves changes to peptidoglycan and the ability to elicit an immune response.

Frirdich E, Biboy J, Pryjma M, Lee J, Huynh S, Parker CT, Girardin SE, Vollmer W, Gaynor EC.

Mol Microbiol. 2019 May 9. doi: 10.1111/mmi.14269. [Epub ahead of print]

PMID:
31070821
9.

From invisibility to readability: Recovering the ink of Herculaneum.

Parker CS, Parsons S, Bandy J, Chapman C, Coppens F, Seales WB.

PLoS One. 2019 May 8;14(5):e0215775. doi: 10.1371/journal.pone.0215775. eCollection 2019.

10.

Influence of video-based feedback on self-assessment accuracy of endoscopic skills: a randomized controlled trial.

Scaffidi MA, Walsh CM, Khan R, Parker CH, Al-Mazroui A, Abunassar M, Grindal AW, Lin P, Wang C, Bechara R, Grover SC.

Endosc Int Open. 2019 May;7(5):E678-E684. doi: 10.1055/a-0867-9626. Epub 2019 May 3.

11.

Psychiatric Emergencies in Nonpsychiatric Settings: Perception Precludes Preparedness.

Parker CB.

Psychosomatics. 2019 Mar 26. pii: S0033-3182(19)30062-3. doi: 10.1016/j.psym.2019.03.006. [Epub ahead of print]

PMID:
31053420
12.

Campylobacter jejuni Demonstrates Conserved Proteomic and Transcriptomic Responses When Co-cultured With Human INT 407 and Caco-2 Epithelial Cells.

Negretti NM, Clair G, Talukdar PK, Gourley CR, Huynh S, Adkins JN, Parker CT, Corneau CM, Konkel ME.

Front Microbiol. 2019 Apr 11;10:755. doi: 10.3389/fmicb.2019.00755. eCollection 2019.

13.

Reduction in energy for electrochemical disinfection of E. coli in urine simulant.

Raut AS, Parker CB, Klem EJD, Stoner BR, Deshusses MA, Glass JT.

J Appl Electrochem. 2019;49(5):443-453. doi: 10.1007/s10800-019-01292-4. Epub 2019 Mar 6.

14.

A Tool for Shared Decision Making on Referral for Prostate Biopsy in the Primary Care Setting: Integrating Risks of Cancer with Life Expectancy.

Verbeek JFM, Nieboer D, Parker C, Kattan MW, Steyerberg EW, Roobol MJ.

J Pers Med. 2019 Apr 22;9(2). pii: E19. doi: 10.3390/jpm9020019.

15.

Active feminization of the preoptic area occurs independently of the gonads in Amphiprion ocellaris.

Dodd LD, Nowak E, Lange D, Parker CG, DeAngelis R, Gonzalez JA, Rhodes JS.

Horm Behav. 2019 Jun;112:65-76. doi: 10.1016/j.yhbeh.2019.04.002. Epub 2019 Apr 11.

PMID:
30959023
16.

An optimized assay for detecting Encephalitozoon intestinalis and Enterocytozoon bieneusi in dairy calf feces using polymerase chain reaction technology.

Jenkins MC, O'Brien CN, Parker C.

J Parasit Dis. 2019 Mar;43(1):75-82. doi: 10.1007/s12639-018-1060-5. Epub 2018 Dec 1.

PMID:
30956449
17.

Sublethal whole-body irradiation causes progressive premature frailty in mice.

Fielder E, Weigand M, Agneessens J, Griffin B, Parker C, Miwa S, von Zglinicki T.

Mech Ageing Dev. 2019 Jun;180:63-69. doi: 10.1016/j.mad.2019.03.006. Epub 2019 Apr 4.

18.

Viable Eimeria oocysts in poultry house litter at the time of chick placement.

Jenkins MC, Parker CC, O'Brien CN, Ritter D.

Poult Sci. 2019 Apr 5. pii: pez147. doi: 10.3382/ps/pez147. [Epub ahead of print]

PMID:
30953077
19.

Assessment of Crohn's disease-associated small bowel strictures and fibrosis on cross-sectional imaging: a systematic review.

Bettenworth D, Bokemeyer A, Baker M, Mao R, Parker CE, Nguyen T, Ma C, Panés J, Rimola J, Fletcher JG, Jairath V, Feagan BG, Rieder F; Stenosis Therapy and Anti-Fibrotic Research (STAR) Consortium.

Gut. 2019 Jun;68(6):1115-1126. doi: 10.1136/gutjnl-2018-318081. Epub 2019 Apr 3. Review.

20.

Effects of Integrated Telehealth-Delivered Cognitive-Behavioral Therapy for Depression and Insomnia in Rural Older Adults.

Scogin F, Lichstein K, DiNapoli EA, Woosley J, Thomas SJ, LaRocca MA, Byers HD, Mieskowski L, Parker CP, Yang X, Parton J, McFadden A, Geyer JD.

J Psychother Integr. 2018 Sep;28(3):292-309. doi: 10.1037/int0000121.

PMID:
30930607
21.

Dosimetry and Gastrointestinal Toxicity Relationships in a Phase II Trial of Pelvic Lymph Node Radiotherapy in Advanced Localised Prostate Cancer.

Ferreira MR, Thomas K, Truelove L, Khan A, Parker C, Dearnaley DP, Gulliford S.

Clin Oncol (R Coll Radiol). 2019 Jun;31(6):374-384. doi: 10.1016/j.clon.2019.02.012. Epub 2019 Mar 20.

22.

Selection of Tree Nut Allergen Peptide Markers: A Need for Improved Protein Sequence Databases.

Xiong W, McFarland MA, Pirone C, Parker CH.

J AOAC Int. 2019 Mar 19. doi: 10.5740/jaoacint.19-0054. [Epub ahead of print]

PMID:
30890207
23.

Androgen Deprivation Therapy with Postprostatectomy Radiotherapy: For Whom and for How Long?

Dearman C, Parker C.

Eur Urol. 2019 Mar 15. pii: S0302-2838(19)30190-3. doi: 10.1016/j.eururo.2019.03.004. [Epub ahead of print] No abstract available.

PMID:
30885532
24.

Immediate Vacuum Formed Overdenture for a Pediatric Patient with Ectodermal Dysplasia.

Levy-Bercowski D, Abreu A, Parker C, Riggs B, Rockman R.

J Dent Child (Chic). 2018 Sep 15;85(3):139-142.

PMID:
30869591
25.

Identification of Salmonella Taxon-Specific Peptide Markers to the Serovar Level by Mass Spectrometry.

Chen SH, Parker CH, Croley TR, McFarland MA.

Anal Chem. 2019 Apr 2;91(7):4388-4395. doi: 10.1021/acs.analchem.8b04843. Epub 2019 Mar 25.

PMID:
30860807
26.

Experiences of gender-based violence among female sex workers, men who have sex with men, and transgender women in Latin America and the Caribbean: a qualitative study to inform HIV programming.

Evens E, Lanham M, Santi K, Cooke J, Ridgeway K, Morales G, Parker C, Brennan C, de Bruin M, Desrosiers PC, Diaz X, Drago M, McLean R, Mendizabal M, Davis D, Hershow RB, Dayton R.

BMC Int Health Hum Rights. 2019 Mar 5;19(1):9. doi: 10.1186/s12914-019-0187-5.

27.

Outcomes of patients with childhood B-cell precursor acute lymphoblastic leukaemia with late bone marrow relapses: long-term follow-up of the ALLR3 open-label randomised trial.

Parker C, Krishnan S, Hamadeh L, Irving JAE, Kuiper RP, Révész T, Hoogerbrugge P, Hancock J, Sutton R, Moorman AV, Saha V.

Lancet Haematol. 2019 Apr;6(4):e204-e216. doi: 10.1016/S2352-3026(19)30003-1. Epub 2019 Feb 27.

28.

Prostate Radiotherapy for Metastatic Hormone-sensitive Prostate Cancer: A STOPCAP Systematic Review and Meta-analysis.

Burdett S, Boevé LM, Ingleby FC, Fisher DJ, Rydzewska LH, Vale CL, van Andel G, Clarke NW, Hulshof MC, James ND, Parker CC, Parmar MK, Sweeney CJ, Sydes MR, Tombal B, Verhagen PC, Tierney JF; STOPCAP M1 Radiotherapy Collaborators.

Eur Urol. 2019 Feb 27. pii: S0302-2838(19)30111-3. doi: 10.1016/j.eururo.2019.02.003. [Epub ahead of print]

29.

Phase III Trial of PROSTVAC in Asymptomatic or Minimally Symptomatic Metastatic Castration-Resistant Prostate Cancer.

Gulley JL, Borre M, Vogelzang NJ, Ng S, Agarwal N, Parker CC, Pook DW, Rathenborg P, Flaig TW, Carles J, Saad F, Shore ND, Chen L, Heery CR, Gerritsen WR, Priou F, Langkilde NC, Novikov A, Kantoff PW.

J Clin Oncol. 2019 May 1;37(13):1051-1061. doi: 10.1200/JCO.18.02031. Epub 2019 Feb 28.

PMID:
30817251
30.

Engineering Polymer-Binding Bispecific Antibodies for Enhanced Pretargeted Delivery of Nanoparticles to Mucus-Covered Epithelium.

Huckaby JT, Parker CL, Jacobs TM, Schaefer A, Wadsworth D, Nguyen A, Wang A, Newby J, Lai SK.

Angew Chem Int Ed Engl. 2019 Apr 16;58(17):5604-5608. doi: 10.1002/anie.201814665. Epub 2019 Mar 21.

PMID:
30811861
31.

Update on C-reactive protein and fecal calprotectin: are they accurate measures of disease activity in Crohn's disease?

Ma C, Battat R, Parker CE, Khanna R, Jairath V, Feagan BG.

Expert Rev Gastroenterol Hepatol. 2019 Apr;13(4):319-330. doi: 10.1080/17474124.2019.1563481. Epub 2019 Jan 3.

PMID:
30791776
32.

Implementation of the Champions for Skin Integrity model to improve leg and foot ulcer care in the primary healthcare setting.

Parker CN, Shuter P, Maresco-Pennisi D, Sargent J, Collins L, Edwards HE, Finlayson KJ.

J Clin Nurs. 2019 Jul;28(13-14):2517-2525. doi: 10.1111/jocn.14826. Epub 2019 Mar 24.

PMID:
30791154
33.

Controversies in Inflammatory Bowel Disease: Exploring Clinical Dilemmas Using Cochrane Reviews.

East JE, Boyapati RK, Torres J, Parker CE, MacDonald JK, Chande N, Feagan BG.

Inflamm Bowel Dis. 2019 Feb 21;25(3):472-478. doi: 10.1093/ibd/izy268.

PMID:
30789982
34.

Stigmatization and knowledge of anorexia nervosa.

Varnado-Sullivan PJ, Parker CC, Rohner A.

Eat Weight Disord. 2019 Feb 19. doi: 10.1007/s40519-019-00655-2. [Epub ahead of print]

PMID:
30784020
35.

Addition of radium-223 to abiraterone acetate and prednisone or prednisolone in patients with castration-resistant prostate cancer and bone metastases (ERA 223): a randomised, double-blind, placebo-controlled, phase 3 trial.

Smith M, Parker C, Saad F, Miller K, Tombal B, Ng QS, Boegemann M, Matveev V, Piulats JM, Zucca LE, Karyakin O, Kimura G, Matsubara N, Nahas WC, Nolè F, Rosenbaum E, Heidenreich A, Kakehi Y, Zhang A, Krissel H, Teufel M, Shen J, Wagner V, Higano C.

Lancet Oncol. 2019 Mar;20(3):408-419. doi: 10.1016/S1470-2045(18)30860-X. Epub 2019 Feb 6.

PMID:
30738780
36.

Observations of Multiple Nuclear Reaction Histories and Fuel-Ion Species Dynamics in Shock-Driven Inertial Confinement Fusion Implosions.

Sio H, Frenje JA, Le A, Atzeni S, Kwan TJT, Gatu Johnson M, Kagan G, Stoeckl C, Li CK, Parker CE, Forrest CJ, Glebov V, Kabadi NV, Bose A, Rinderknecht HG, Amendt P, Casey DT, Mancini R, Taitano WT, Keenan B, Simakov AN, Chacón L, Regan SP, Sangster TC, Campbell EM, Seguin FH, Petrasso RD.

Phys Rev Lett. 2019 Jan 25;122(3):035001. doi: 10.1103/PhysRevLett.122.035001.

PMID:
30735406
37.

Predictors of cisplatin-induced ototoxicity and survival in chemoradiation treated head and neck cancer patients.

Teft WA, Winquist E, Nichols AC, Kuruvilla S, Richter S, Parker C, Francis P, Trinnear M, Lukovic J, Bukhari N, Choi YH, Welch S, Palma DA, Yoo J, Kim RB.

Oral Oncol. 2019 Feb;89:72-78. doi: 10.1016/j.oraloncology.2018.12.010. Epub 2018 Dec 21.

PMID:
30732962
38.

Antibiotics for induction and maintenance of remission in Crohn's disease.

Townsend CM, Parker CE, MacDonald JK, Nguyen TM, Jairath V, Feagan BG, Khanna R.

Cochrane Database Syst Rev. 2019 Feb 7;2:CD012730. doi: 10.1002/14651858.CD012730.pub2.

PMID:
30731030
39.

Phase 1 Trial of an RNA Interference Therapy for Acute Intermittent Porphyria.

Sardh E, Harper P, Balwani M, Stein P, Rees D, Bissell DM, Desnick R, Parker C, Phillips J, Bonkovsky HL, Vassiliou D, Penz C, Chan-Daniels A, He Q, Querbes W, Fitzgerald K, Kim JB, Garg P, Vaishnaw A, Simon AR, Anderson KE.

N Engl J Med. 2019 Feb 7;380(6):549-558. doi: 10.1056/NEJMoa1807838.

PMID:
30726693
40.

Histologic Healing Rates of Medical Therapies for Ulcerative Colitis: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.

Battat R, Duijvestein M, Guizzetti L, Choudhary D, Boland BS, Dulai PS, Parker CE, Nguyen TM, Singh S, Vande Casteele N, Pai RK, Feagan BG, Sandborn WJ, Jairath V.

Am J Gastroenterol. 2019 May;114(5):733-745. doi: 10.14309/ajg.0000000000000111.

PMID:
30694863
41.

Implementing the Communities That Care Prevention System: Challenges, Solutions, and Opportunities in an Urban Setting.

Brady SS, Parker CJ, Jeffries EF, Simpson T, Brooke-Weiss BL, Haggerty KP.

Am J Prev Med. 2018 Nov;55(5S1):S70-S81. doi: 10.1016/j.amepre.2018.05.019.

42.

Community Readiness to Adopt the Communities That Care Prevention System in an Urban Setting.

Parker CJ, Winston Iii W, Simpson T, Brady SS.

Am J Prev Med. 2018 Nov;55(5S1):S59-S69. doi: 10.1016/j.amepre.2018.05.022.

43.

Complete Genome Sequences of Three Shiga Toxin-Producing Escherichia coli O111:H8 Strains Exhibiting an Aggregation Phenotype.

Parker CT, Huynh S, Bono JL, Miller WG, Cooley MB, Brandl MT.

Microbiol Resour Announc. 2019 Jan 3;8(1). pii: e01335-18. doi: 10.1128/MRA.01335-18. eCollection 2019 Jan.

44.

Impact of Ga-68-PSMA PET/CT on management in prostate cancer patients with very early biochemical recurrence after radical prostatectomy.

Bashir U, Tree A, Mayer E, Levine D, Parker C, Dearnaley D, Oyen WJG.

Eur J Nucl Med Mol Imaging. 2019 Apr;46(4):901-907. doi: 10.1007/s00259-018-4249-z. Epub 2019 Jan 8.

45.

Negative Events During Adulthood are Associated With Symptom Severity and Altered Stress Response in Patients With Irritable Bowel Syndrome.

Parker CH, Naliboff BD, Shih W, Presson AP, Videlock EJ, Mayer EA, Chang L.

Clin Gastroenterol Hepatol. 2019 Jan 4. pii: S1542-3565(19)30002-3. doi: 10.1016/j.cgh.2018.12.029. [Epub ahead of print]

PMID:
30616026
46.

Improving Timeliness of Oncology Assessment and Cancer Treatment Through Implementation of a Multidisciplinary Lung Cancer Clinic.

Stone CJL, Robinson A, Brown E, Mates M, Falkson CB, Owen T, Ashworth A, Parker CM, Mahmud A, Tomiak A, Thain SK, Gregg R, Reid KR, Chung W, Digby GC.

J Oncol Pract. 2019 Feb;15(2):e169-e177. doi: 10.1200/JOP.18.00214. Epub 2019 Jan 7.

PMID:
30615586
47.

Facing Opioids in the Shadow of the HIV Epidemic.

Parker CM, Hirsch JS, Hansen HB, Branas C, Martins S.

N Engl J Med. 2019 Jan 3;380(1):1-3. doi: 10.1056/NEJMp1813836. No abstract available. Erratum in: N Engl J Med. 2019 Jan 24;380(4):402.

48.

Are children with unrecognised psychiatric disorders being excluded from school? A secondary analysis of the British Child and Adolescent Mental Health Surveys 2004 and 2007.

Parker C, Tejerina-Arreal M, Henley W, Goodman R, Logan S, Ford T.

Psychol Med. 2018 Dec 21:1-12. doi: 10.1017/S0033291718003513. [Epub ahead of print]

PMID:
30572975
49.

Systematic review with meta-analysis: high prevalence and cost of continued aminosalicylate use in patients with ulcerative colitis escalated to immunosuppressive and biological therapies.

Ma C, Guizzetti L, Cipriano LE, Parker CE, Nguyen TM, Gregor JC, Chande N, Feagan BG, Jairath V.

Aliment Pharmacol Ther. 2019 Feb;49(4):364-374. doi: 10.1111/apt.15090. Epub 2018 Dec 19. Review.

PMID:
30569460
50.

Complete Genome Sequence of Acinetobacter radioresistens Strain LH6, a Multidrug-Resistant Bacteriophage-Propagating Strain.

Crippen CS, Huynh S, Miller WG, Parker CT, Szymanski CM.

Microbiol Resour Announc. 2018 Aug 9;7(5). pii: e00929-18. doi: 10.1128/MRA.00929-18. eCollection 2018 Aug.

Supplemental Content

Loading ...
Support Center